Science with a purpose: Expanding patient access with affordable biologic treatments.
We are a pioneering biopharmaceutical company in LATAM
Committed to transforming healthcare through innovation and integrity.
At Saya Biologics, we are not just witnessing the problem — we are taking action.
Born in Latin America, we are driven by a sense of urgency to deliver innovative and affordable biological therapies to those who need them most. Through strategic partnerships, agile execution, and a deep understanding of the region's healthcare realities, we are building a robust pipeline of innovative and biosimilar medicines — ready to change the standard of care.
Our mission is clear
To break down barriers and bring high-qualityBreaking down barriers and bringing high-quality medicines to the patients who need them most.
We achieve this through international partnerships to register, market, and distribute biological and biosimilar medicines in LATAM.
Timely Availability
Ensuring an adequate supply of medicines is essential for the success of treatment and prevention programs. Universal access to medicines is an investment in the well-being and progress of society as a whole.
Deliberate Precision
Committed to precision, efficiency, and excellence in healthcare. Our digital infrastructure and agile processes allow us to operate with the highest standards of quality and safety. Our unwavering dedication to excellence guides every decision, building trust in every step we take.
Human-Centered
By putting patients at the center of our efforts, we ensure that every innovation and advancement is driven by a genuine desire to improve lives. It's not just about science; it's about compassion, connection, and the profound impact we can have on the lives of others through understanding and care.
Addressing the unmet medical needs
Biologic drugs could improve and extend the lives of over 1 million patients diagnosed each year in Latin America with serious and hard-to-treat conditions.
However, up to 70% of patients
that could be eligible for these drugs, are given other, less-effective alternatives.
Our goal is to bring that number down to 0% by 2035.
Join us in revolutionizing access to biologics
Together, we can ensure equitable healthcare for patients across the region, and improve the quality of life.
Get in Touch
Tell us what you’re working on and what you’re looking for in a LATAM partner — together, we can build a partnership that opens doors for patients.
Contact Us
Our team would love to hear from you
